Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | NPC1 | O15118 | 3/20 | 0.60 |
| ▸ | RAB9A | P51151 | 3/20 | 0.60 |
| ▸ | AGXT | P21549 | 2/20 | 0.59 |
| ▸ | DRD3 | P35462 | 1/20 | 0.58 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | PPARG | P37231 | 2/20 | 0.57 |
| ▸ | LTA4H | P09960 | 2/20 | 0.57 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.56 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.56 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29666114 | 1.00 | TDP1 (0.68) | TDP1KDM4EMAPK1NPC1RAB9A | |
| SCHEMBL9576090 | 0.96 | KDM4E (0.63) | TDP1KDM4EMAPK1NPC1RAB9A | |
| SCHEMBL758205 | 0.94 | KDM4E (0.61) | TDP1KDM4EMAPK1NPC1RAB9A | |
| SCHEMBL8746015 | 0.94 | KDM4E (0.61) | TDP1KDM4EMAPK1NPC1RAB9A | |
| SCHEMBL30186210 | 0.94 | KDM4E (0.61) | TDP1KDM4EMAPK1NPC1RAB9A | |
| SCHEMBL11077065 | 0.94 | KDM4E (0.61) | TDP1KDM4EMAPK1NPC1RAB9A | |
| SCHEMBL10587825 | 0.94 | KDM4E (0.61) | TDP1KDM4EMAPK1NPC1RAB9A | |
| SCHEMBL5374714 | 0.94 | KDM4E (0.61) | TDP1KDM4EMAPK1NPC1RAB9A | |
| SCHEMBL22753136 | 0.94 | KDM4E (0.61) | TDP1KDM4EMAPK1NPC1RAB9A | |
| SCHEMBL11223915 | 0.94 | KDM4E (0.61) | TDP1KDM4EMAPK1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | claimed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| WO-2023192424-A1 | VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-05 | — | — | WO | claimed |
| CN-108689809-A | A kind of clean preparation method of bromelia and application | 盐城市东港药物化工发展有限公司 | 2018-10-23 | — | — | CN | claimed |
| CN-101781177-A | Beta-naphthol butyl ether synthesized by microwave irradiation | NANTONG XINYING DESIGN & SERVI | 2010-07-21 | — | — | CN | claimed |
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | CORN PRODUCTS DEV INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | disclosed |
| EP-4561366-A1 | FLAVOR MODIFYING COMPOSITION | CORN Products Development Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| US-20250081996-A1 | FLAVOR MODIFYING COMPOSITION | PURECIRCLE SDN BHD (MY) | 2025-03-13 | — | — | US | disclosed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | disclosed |
| US-12030877-B2 | Prostaglandin E synthase inhibitors and methods for utilizing the same | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
| US-12030877-B2 | Prostaglandin E synthase inhibitors and methods for utilizing the same | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
| CN-1224524-C | Benzodiazolyl compound, and compound for optical recording medium | MITSUI CHEMICALS INC (JP) | 2005-10-26 | — | — | CN | disclosed |
| CN-1646325-A | Rewritable optical information recording medium and recording/reproducing method, recording/reproducing device | SONY CORP MITSUI CHEMICALS INC (JP) | 2005-07-27 | — | — | CN | disclosed |
| CN-1176936-C | Carbamycin derivatives and pharmaceutical compositions containing the same | ������������ʽ���� | 2004-11-24 | — | — | CN | disclosed |
| US-20040229162-A1 | Photoacid generators, chemically amplified resist compositions, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-11-18 | — | — | US | disclosed |
| CN-1406182-A | Benzodiazolyl compound, optical recording medium compound | MITSUI CHEMICALS INC (JP) | 2003-03-26 | — | — | CN | disclosed |
| CN-1382152-A | Novel A-500359 derivatives | SANKYO CO (JP) | 2002-11-27 | — | — | CN | disclosed |
| EP-0733364-A1 | MEDICINAL COMPOSITION FOR CIRCULATORY ORGAN | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1996-09-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | TAS2R42, TAS2R7, TAS2R31 | TDP1 1850/4885KDM4E 4248/4885MAPK1 2601/4885 |
| US-12030877-B2 | Prostaglandin E synthase inhibitors and methods for utilizing the same | PTGES, PTGS1, PTGES2 | TDP1 2276/4885KDM4E 2780/4885MAPK1 1649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.